- Severe allergic reaction (eg, anaphylaxis) after a previous dose of any hepatitis A-containing or hepatitis B-containing vaccine, or to any component of TWINRIX, including yeast and neomycin, is a contraindication to administration of TWINRIX
See full Important Safety Information below
Diagnosis Codes
ICD-10-CM codes are used to report diseases and conditions. These will be needed on the CMS-1500 form.
View More InformationPrintable Summary Sheet
This PDF provides a summary of CPT codes for GSK vaccines.
View Summary SheetThis section provides the vaccine product codes as well as some common administration codes associated with immunization using TWINRIX. Administration codes will vary based on the service provided. Please refer to your most up-to-date Current Procedural Terminology (CPT) and International Classification of Diseases (ICD) manuals for appropriate coding.
INDICATION
TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. TWINRIX is approved for use in persons 18 years of age or older.
| CPT Code |
Description [33] | NDCs* | ICD-10-CM Code [8]** |
|
|---|---|---|---|---|
| 18 years of age and older dose: 1 mL Standard dosing: A series of three 1-mL doses given on a 0-, 1-, and 6-month schedule |
90636 | TWINRIX is available in 1-mL single-dose vials and 1-mL single-dose prefilled disposable Tip-Lok® syringes (packaged without needles) (Preservative Free Formulation). | Z23 | |
| Vial in Package of 10 | ||||
| Vial: Outer Carton: |
NDC 58160-815-01 NDC 58160-815-11 | |||
| Syringe in Package of 10 | ||||
| Syringe: Outer Carton: |
NDC 58160-815-43 NDC 58160-815-52 |
| * | Note that some payers require an 11-digit NDC, which involves adding a "0" immediately after the first hyphen in each GSK NDC. For example, when reporting NDC 58160-820-11 to TRICARE, it becomes NDC 58160-0820-11. [14] |
| ** | With the implementation of ICD-10-CM, all vaccine-related encounters are reported as code Z23 for all vaccines given. |
| Immunization Administration Codes (CPT) [6] | |
|---|---|
| CPT | Description |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid) |
| +90472 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) |
| Adapted from American Medical Association. CPT 2016 Professional Edition. | |
IMPORTANT SAFETY INFORMATION
- Severe allergic reaction (eg, anaphylaxis) after a previous dose of any hepatitis A-containing or hepatitis B-containing vaccine, or to any component of TWINRIX, including yeast and neomycin, is a contraindication to administration of TWINRIX
- The tip caps of the prefilled syringes for TWINRIX contain natural rubber latex, which may cause allergic reactions
- Syncope (fainting) can occur in association with administration of injectable vaccines. Procedures should be in place to avoid falling injury and to restore cerebral perfusion following syncope
- Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to TWINRIX
- In clinical trials with TWINRIX, the most frequently reported solicited adverse reactions were injection-site soreness and headache
- Vaccination with TWINRIX may not result in protection in all vaccine recipients
TWINRIX and Tip-Lok are registered trademarks of the GSK group of companies.
815516R0 December 2016
Please note that this website is provided for informational purposes only and is not intended to serve as comprehensive training on medical billing and coding. Additional training on medical coding may be required. The information on this website is believed to be accurate as of the date of publication. Users should independently verify accuracy.
Healthcare providers are responsible for making the ultimate decision on when to use a specific product based on clinical recommendations and how to bill for products and related services rendered. Consult third-party insurers' guidelines for specific information regarding the billing and reporting of services rendered.
You are encouraged to report vaccine adverse events to the US Department of Health and Human Services.Visit www.vaers.hhs.gov to file a report, or call 1-800-822-7967.
This website is funded and developed by GSK.
This site is intended for US healthcare professionals only.
©2017 GSK group of companies or its licensor. Produced in USA.
